Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Relistor

- PMLiVE

Death leads to recall of batch of Takeda’s Rienso in Switzerland

Marketing partner Amag also reports three other hypersensitivity reactions

- PMLiVE

Royalty Pharma raises Elan bid as deals keep coming

Values Elan at about $6.5bn

- PMLiVE

Actavis to buy Warner Chilcott in $8.5bn deal

Combined company will have annual revenues of about $11bn

- PMLiVE

New vortioxetine studies reinforce efficacy in depression

Supports marketing applications from Takeda and Lundbeck

Bayer symbol

Bayer boosts consumer care business with Steigerwald purchase

Fuels ambition to become world leader in OTC medicines

- PMLiVE

Takeda rides out Actos decline as fiscal 2012 sales rise

Nycomed acquisition continues to bolster revenues

- PMLiVE

Takeda buys vaccines specialist Inviragen

Acquires vaccine candidates against dengue fever and hand, foot and mouth disease in $250m deal

Pharma deals during April 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for April 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Rumoured Valeant merger with Actavis stalls

Wall Street Journal claims talks have fallen through on $13bn merger

- PMLiVE

Hikma to retain injectables unit

Result of strategic review after acquisition interest

- PMLiVE

US-based Millennium launches blood cancer website

The Takeda Oncology Company roll out new multiple myeloma website

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links